我院2011年骨质疏松用药分析
Usage of anti-osteoporosis drugs in our hospital in 2011
  
DOI:10.3969/j.issn.1006.7108.2012.08.011
中文关键词:  抗骨质疏松药  用药频度  用药分析
英文关键词:Anti-osteoporosis drugs  DDDs  Medication analysis
基金项目:
作者单位
王振山 210024 南京市江苏省老年医院药剂科 
摘要点击次数: 871
全文下载次数: 704
中文摘要:
      目的 了解我院骨质疏松用药的基本情况及趋势。方法 对我院2011年全年抗骨质疏松药物的销售金额、用药频度及日均费用等进行回顾性分析。结果 我院抗骨质疏松用药中阿法骨化醇销售金额最高,DDDs也最高;日均费用以鲑鱼降钙素注射液(密盖息注射液)最高。结论 维生素D 制剂及钙剂,在防治骨质疏松症的应用中占主导地位,另外降钙素和双膦酸盐在骨质疏松的治疗中也占有重要的地位。
英文摘要:
      Objective To investigate the basic situation and trend of the use of anti-osteoporosis drugs. Methods The consumption sum,usage frequency of drug,and average daily cost of anti-osteoporosis drugs were retrospectively analyzed. Results Alfa-calcidol DDDs and the consumption sum was the most used anti-osteoporosis drugs. The daily cost was the highest in the salmon calcitonin injection. Conclusion Vitamin D and calcium are the mainly used drugs for the prevention and treatment of osteoporosis. Besides,calcitonin and bisphosphonates also play an important role in the treatment of osteoporosis.
查看全文  查看/发表评论  下载PDF阅读器
关闭
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=DA201693A5CA966C9CE39A6FD6E293AA550C06B5C919E1B84BB339ED49513AE33353E51BF4D851A831FA0AD08EB2BBE448CAAE63F0D5DC41C5906E3422A47153&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=527A01A248DACB72&jid=CA678592D11E309E8E3FB3B2BFE9BE1A&yid=99E9153A83D4CB11&aid=B7AA4CDA3D36B85D59ECCF8BC12031CB&vid=&iid=5D311CA918CA9A03&sid=00B9006659EBD8AC&eid=D142CE623F3DC48A9F996D1B13DC11CA&fileno=201208011&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="527A01A248DACB72"; var my_jid="CA678592D11E309E8E3FB3B2BFE9BE1A"; var my_yid="99E9153A83D4CB11"; var my_aid="B7AA4CDA3D36B85D59ECCF8BC12031CB";